KM Research Hub
← 返回论文库
已完成 入排:排除 图源:可得 入排置信度 0.96

Beyond the first cut: Impact of repeat surgery versus boost on breast induration-A post hoc analysis from the DBCG HYPO & PBI trials.

Kristine Wiborg Høgsbjerg, Else Maae, Mette Holck Nielsen, Marie Louise Holm Milo, Maja Vestmø Maraldo, Peer Michael Christiansen, Mette Skovhus Thomsen, Jens Overgaard, Birgitte Vrou Offersen, Danish Breast Cancer Group Radiotherapy Committee

Breast 84 104587

PMID41043314
PMCIDPMC12516053
DOI10.1016/j.breast.2025.104587
发表日期2025-10-03
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
摘要

摘要

PURPOSE: Following breast-conserving surgery (BCS), patients with narrow surgical margins frequently undergo repeat surgery (RS) or receive a tumour-bed boost to reduce the risk of local recurrence. Both interventions may increase the risk of late toxicity, including breast induration and adverse cosmetic outcomes. Comparative long-term data on these outcomes remain limited. This post hoc analysis assessed the impact of RS and tumour-bed boost on grade 2-3 breast induration and cosmetic outcomes in patients receiving whole-breast irradiation (WBI) for early-stage breast cancer or ductal carcinoma in situ (DCIS). RESULTS: The analysis included 1919 patients from two multicentre randomised phase III trials within the Danish Breast Cancer Group (DBCG): DBCG HYPO (WBI 50Gy/25fr versus 40Gy/15fr) and DBCG PBI (40Gy/15fr, WBI versus partial breast irradiation (PBI)). Of these, 303 patients (16 %) underwent RS and 220 patients (11 %) received a boost. Patients were categorised into four groups: 'RS and boost', 'boost only', 'RS only', and 'No RS, no boost'. At 5 years, the cumulative incidence of grade 2-3 breast induration was highest in the 'RS and boost' group (30.7 %), followed by 'boost only' (25.7 %), 'RS only' (18.1 %), and 'No RS, no boost' (13.5 %). Adjusted hazard ratios confirmed this pattern. No significant differences in cosmetic outcomes were observed between the 'RS only' and 'boost only' groups at 3 or 5 years. CONCLUSIONS: A tumour-bed boost was associated with a higher risk of breast induration compared to RS, with no difference in cosmetic outcome.

KM 提取结果

2 个 Figure · 2 个 KM 面板

进入结果中心
KM Figure1 个面板

Fig. 1

Fig. 1 Cumulative incidence of breast induration: Repeat surgery yes/no. The cumulative incidence of grade 2–3 breast induration at 3 and 5 years, estimated at 3.5 and 5.5 years, respectively. RS, repeat surgery. NoRS, no repeat surgery. HR, hazard ratio; Unadj., unadjusted; adj. HR was adjusted for age, smoking status, irradiated volume (V95 %), endocrine therapy, and dose/fractionation.

Induration_grade_2-3

Cumulative incidence of breast induration

Fig. 1 · Panel Induration_grade_2-3

complete 待 EXE 对齐 预期 2 条 已提取 2 条

Panel Induration_grade_2-3 是同一 Fig. 1 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 1:extreme upward reversal
查看结果
KM Figure1 个面板

Fig. 2

Fig. 2 Cumulative incidence of breast induration: Repeat surgery vs. boost. The cumulative incidence of grade 2–3 breast induration at 3 and 5 years, estimated at 3.5 and 5.5 years, respectively. RS, repeat surgery. B, boost.

Induration_grade_2-3

Cumulative incidence of grade 2-3 breast induration

Fig. 2 · Panel Induration_grade_2-3

quality_warning 待 EXE 对齐 预期 4 条 已提取 2 条

Panel Induration_grade_2-3 是同一 Fig. 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示疑似重复轨迹:同一条 KM 曲线可能被重复识别疑似图例或人工水平线:轨迹出现不合理的共同平台曲线缺失:预期 4 条,实际恢复 2 条疑似重复轨迹:同一条 KM 曲线可能被重复识别
查看结果
其他 Figure(1,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 3Fig. 3 Hazard ratios for risk of breast induration. Adjusted hazard ratios for grade 2–3 breast induration in three treatment groups: group 1 (RS + B), group 2 (B only), and group 3 (RS only). Group 4 (No RS, No B) served as the reference. RS, repeat surgery; B, boost; HR, hazard ratio. HRs were adjusted for age, smoking status, irradiated volume (V95 %), endocrine therapy, and dose/fractionation.
非 KM Figure